Paperpal Prime Logo

Diabetology and Metabolic Syndrome : Impact Factor & More

eISSN: 1758-5996pISSN: 1758-5996
JournalOpen Access

Key Metrics

CiteScore
5.7
Impact Factor
< 5
SJR
Q2Internal Medicine
SNIP
1.44
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Diabetology and Metabolic Syndrome

Diabetology and Metabolic Syndrome Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2290 | USD 2790 | GBP 1990
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorBrazilian Diabetes Society
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Diabetology and Metabolic Syndrome ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Diabetology and Metabolic Syndrome

Correction: Polygenic risk and air pollution trends in relation to type 2 diabetes: evidence from the Taiwan Biobank
  • 4 Aug 2026
  • Diabetology & Metabolic Syndrome
Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal
  • 30 Jul 2026
  • Diabetology & Metabolic Syndrome
Glycemic instability in renal decline: a review of HbA1c variability and outcomes in chronic kidney disease.
  • 21 Jul 2026
  • Diabetology & metabolic syndrome
Synergistic effect of AIP and cystatin C: a study on cardiovascular risk prediction in populations with different glycemic statuses.
  • 17 Jul 2026
  • Diabetology & metabolic syndrome
Beyond TIR: the impact of technology on glucose variability in a cohort of preschool children with T1D.
  • 15 Jul 2026
  • Diabetology & metabolic syndrome
Real-world efficacy and safety of SGLT2 inhibitor add-on triple therapy in south indian patients with type 2 diabetes mellitus: a 24-week prospective observational cohort study.
  • 14 Jul 2026
  • Diabetology & metabolic syndrome
Correction: Polygenic risk and air pollution trends in relation to type 2 diabetes: evidence from the Taiwan Biobank
  • 4 Aug 2026
  • Diabetology & Metabolic Syndrome
Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal
  • 30 Jul 2026
  • Diabetology & Metabolic Syndrome
Glycemic instability in renal decline: a review of HbA1c variability and outcomes in chronic kidney disease.
  • 21 Jul 2026
  • Diabetology & metabolic syndrome
Synergistic effect of AIP and cystatin C: a study on cardiovascular risk prediction in populations with different glycemic statuses.
  • 17 Jul 2026
  • Diabetology & metabolic syndrome
Beyond TIR: the impact of technology on glucose variability in a cohort of preschool children with T1D.
  • 15 Jul 2026
  • Diabetology & metabolic syndrome
Real-world efficacy and safety of SGLT2 inhibitor add-on triple therapy in south indian patients with type 2 diabetes mellitus: a 24-week prospective observational cohort study.
  • 14 Jul 2026
  • Diabetology & metabolic syndrome

FAQs on Diabetology and Metabolic Syndrome